Superworth

Cytokinetics profit margin CYTK

Gross, operating and net profit as a share of revenue over the last twelve months, from 2014.

Net margin, 12 months
n/m
not a meaningful number
Peer median
15.0%

Cytokinetics' net margin works out at −1321% over the last twelve months, but it is not a meaningful number: a margin outside minus 100% to 100% is moved by items that are not sales.

Profit margin over time

OperatingNet

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearNet marginOperating margin
FY2025n/an/a
FY2024n/an/a
FY2023n/an/a
FY2022n/an/a
FY2021n/an/a
FY2020n/an/a
FY2019n/an/a
FY2018n/an/a
FY2017n/an/a
FY201615.5%17.6%
FY2015n/an/a
FY2014−31.2%−31.4%
FY2013n/an/a
FY2012n/an/a
FY2011n/an/a

Quarter by quarter

QuarterEndedNet margin, 12 monthsChange on a year
Q2 FY26n/an/a
Q1 FY26n/an/a
Q4 FY25n/an/a
Q3 FY25n/an/a
Q2 FY25n/an/a
Q1 FY25n/an/a
Q4 FY24n/an/a
Q3 FY24n/an/a
Q2 FY24n/an/a
Q1 FY24n/an/a
Q4 FY23n/an/a
Q3 FY23n/an/a

Against its peers

Companies in Drug Manufacturers - General nearest Cytokinetics' size, closest first, today.

CompanyProfit margin
CYTKCytokineticsn/m
TGTXTG Therapeutics55.2%
PTGXProtagonist Therapeutics29.4%
CORTCorcept Therapeutics6.6%
ALKSAlkermes plc.4.0%
BMRNBiomarin Pharmaceutical2.1%
AMRXAmneal Pharmaceuticals5.0%
LGNDLigand Pharmaceuticals67.9%
KNSAKiniksa Pharmaceuticals International9.6%
JAZZJazz Pharmaceuticals20.4%
INDVIndivior Pharmaceuticals26.7%
Peer median15.0%

What the profit margin tells you

Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).

Compare within an industry. 10% is superb for a retailer and poor for a software company.

More on Cytokinetics

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.